Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders
Authors:
Open Access
- 26 February 2019
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Stem Cells
- Vol. 11 (2) , 55-72
Abstract
Rational use of mesenchymal stem cells in the treatment of autism spectrum disordersKeywords
This publication has 192 references indexed in Scilit:
- Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood AutismJAMA, 2013
- The role of immune dysfunction in the pathophysiology of autismBrain, Behavior, and Immunity, 2012
- Activation of the maternal immune system induces endocrine changes in the placenta via IL-6Brain, Behavior, and Immunity, 2011
- Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disordersJournal of Neuroimmunology, 2011
- Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcomeBrain, Behavior, and Immunity, 2011
- Connecting Genes to Brain in the Autism Spectrum DisordersArchives of Neurology, 2010
- Modulation of bone marrow stromal cell functions in infectious diseases by toll-like receptor ligandsJournal of Molecular Medicine, 2009
- Elevated immune response in the brain of autistic patientsJournal of Neuroimmunology, 2009
- The killer's kiss: the many functions of NK cell immunological synapsesCurrent Opinion in Cell Biology, 2008
- Developmental effects of SSRIs: lessons learned from animal studiesInternational Journal of Developmental Neuroscience, 2007